Koselugo (selumetinib) — Medica

Initial criteria

• Patient meets ONE of the following (i or ii): i. Patient is 1 to 18 years of age; OR ii. Patient meets BOTH of the following (a and b): a) Patient is ≥ 19 years of age; AND b) Patient has been previously started on therapy with Koselugo prior to becoming 19 years of age
• Prior to starting Koselugo, the patient had symptomatic, inoperable plexiform neurofibromas, according to the prescriber

Approval duration

1 year